IL157726A0 - Soluble heterodimeric cytokine receptor - Google Patents
Soluble heterodimeric cytokine receptorInfo
- Publication number
- IL157726A0 IL157726A0 IL15772602A IL15772602A IL157726A0 IL 157726 A0 IL157726 A0 IL 157726A0 IL 15772602 A IL15772602 A IL 15772602A IL 15772602 A IL15772602 A IL 15772602A IL 157726 A0 IL157726 A0 IL 157726A0
- Authority
- IL
- Israel
- Prior art keywords
- cytokine receptor
- heterodimeric cytokine
- soluble heterodimeric
- immunoglobulin
- subunit
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cosmetics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27456001P | 2001-03-09 | 2001-03-09 | |
US29986501P | 2001-06-21 | 2001-06-21 | |
PCT/US2002/007214 WO2002072607A2 (en) | 2001-03-09 | 2002-03-07 | Soluble heterodimeric cytokine receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
IL157726A0 true IL157726A0 (en) | 2004-03-28 |
Family
ID=26956904
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15772602A IL157726A0 (en) | 2001-03-09 | 2002-03-07 | Soluble heterodimeric cytokine receptor |
IL204299A IL204299A (en) | 2001-03-09 | 2010-03-04 | Il-20 antagonist and medicament containing it |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL204299A IL204299A (en) | 2001-03-09 | 2010-03-04 | Il-20 antagonist and medicament containing it |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1399472B1 (ja) |
JP (1) | JP4009535B2 (ja) |
AT (1) | ATE432942T1 (ja) |
AU (1) | AU2002245652A1 (ja) |
CA (1) | CA2440596C (ja) |
DE (1) | DE60232511D1 (ja) |
DK (1) | DK1399472T3 (ja) |
EA (1) | EA005496B1 (ja) |
ES (1) | ES2327821T3 (ja) |
IL (2) | IL157726A0 (ja) |
WO (1) | WO2002072607A2 (ja) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001040467A1 (en) | 1999-12-03 | 2001-06-07 | Zymogenetics, Inc. | Human cytokine receptor |
US7122632B2 (en) | 1999-12-23 | 2006-10-17 | Zymogenetics, Inc. | Soluble Interleukin-20 receptor |
US20030170823A1 (en) | 1999-12-23 | 2003-09-11 | Presnell Scott R. | Novel cytokine ZCYTO18 |
US6610286B2 (en) | 1999-12-23 | 2003-08-26 | Zymogenetics, Inc. | Method for treating inflammation using soluble receptors to interleukin-20 |
US20030023033A1 (en) * | 2001-07-26 | 2003-01-30 | Laure Dumoutier | Novel class II cytokine receptors and uses thereof |
JP5015404B2 (ja) | 2000-08-08 | 2012-08-29 | ザイモジェネティクス, インコーポレイテッド | 可溶性zcytor11サイトカイン受容体 |
WO2002022153A2 (en) | 2000-09-15 | 2002-03-21 | Zymogenetics, Inc. | Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation |
CA2439961A1 (en) | 2001-03-27 | 2002-10-03 | Zymogenetics, Inc. | Human cytokine receptor |
AU2002337920A1 (en) | 2001-10-19 | 2003-04-28 | Zymogenetics, Inc. | Dimerized growth factor and materials and methods for producing it |
AU2012216499B2 (en) * | 2001-10-19 | 2015-05-28 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
WO2003051384A1 (en) | 2001-12-17 | 2003-06-26 | Zymogenetics, Inc. | Method for treating cervical cancer |
US7241593B2 (en) | 2002-02-11 | 2007-07-10 | Zymogenetics, Inc. | Materials and methods for preparing dimeric growth factors |
CA2480163A1 (en) | 2002-03-22 | 2003-10-09 | Zymogenetics, Inc. | Anti-il-tif antibodies and methods of using in inflammation |
JP2007525437A (ja) * | 2003-03-24 | 2007-09-06 | ザイモジェネティクス, インコーポレイテッド | 抗il−20抗体および結合パートナーならびに炎症において用いる方法 |
EP2087905A2 (en) | 2003-08-08 | 2009-08-12 | Novo Nordisk A/S | Interleukin-20 for treating and diagnosing conditions associated with neovascularisation |
WO2005052001A2 (en) | 2003-11-21 | 2005-06-09 | Zymogenetics, Inc. | Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation |
BRPI0516975A (pt) * | 2004-10-22 | 2008-09-30 | Zymogenetics Inc | anticorpo ou seu fragmento de ligação a antìgeno, composição farmacêutica, imunoconjugado, hibridoma, anticorpo monoclonal, e, uso de um anticorpo ou seu fragmento de ligação a antìgeno |
US20060177447A1 (en) | 2005-02-08 | 2006-08-10 | Wenfeng Xu | Anti-IL-20, anti-IL-22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
JP2008544746A (ja) | 2005-05-12 | 2008-12-11 | ザイモジェネティクス, インコーポレイテッド | 免疫応答を調節するための組成物および方法 |
AU2011219715B2 (en) | 2010-02-26 | 2014-12-11 | Novo Nordisk A/S | Stable antibody containing compositions |
CN102905692B (zh) | 2010-05-28 | 2015-09-16 | 诺沃—诺迪斯克有限公司 | 包含抗体和防腐剂的稳定的多剂量组合物 |
KR102204937B1 (ko) | 2014-06-06 | 2021-01-18 | 브리스톨-마이어스 스큅 컴퍼니 | 글루코코르티코이드-유도 종양 괴사 인자 수용체 (gitr)에 대한 항체 및 그의 용도 |
BR112017025297A2 (pt) | 2015-06-03 | 2018-08-14 | Bristol-Myers Squibb Company | anticorpos anti-gitr para diagnóstico do câncer |
GB201514875D0 (en) * | 2015-08-20 | 2015-10-07 | Autolus Ltd | Receptor |
WO2017087678A2 (en) | 2015-11-19 | 2017-05-26 | Bristol-Myers Squibb Company | Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereof |
US11685787B2 (en) | 2017-05-16 | 2023-06-27 | Bristol-Myers Squibb Company | Treatment of cancer with anti-GITR agonist antibodies |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965704A (en) * | 1997-08-05 | 1999-10-12 | Zymogenetics, Inc. | Class two cytokine receptor-11 |
AU2222700A (en) * | 1998-12-31 | 2000-07-31 | Millennium Pharmaceuticals, Inc. | Class ii cytokine receptor-like proteins and nucleic acids encoding them |
-
2002
- 2002-03-07 AU AU2002245652A patent/AU2002245652A1/en not_active Abandoned
- 2002-03-07 ES ES02713823T patent/ES2327821T3/es not_active Expired - Lifetime
- 2002-03-07 CA CA2440596A patent/CA2440596C/en not_active Expired - Fee Related
- 2002-03-07 IL IL15772602A patent/IL157726A0/xx not_active IP Right Cessation
- 2002-03-07 DE DE60232511T patent/DE60232511D1/de not_active Expired - Lifetime
- 2002-03-07 EA EA200300983A patent/EA005496B1/ru not_active IP Right Cessation
- 2002-03-07 AT AT02713823T patent/ATE432942T1/de active
- 2002-03-07 EP EP02713823A patent/EP1399472B1/en not_active Expired - Lifetime
- 2002-03-07 JP JP2002571520A patent/JP4009535B2/ja not_active Expired - Fee Related
- 2002-03-07 WO PCT/US2002/007214 patent/WO2002072607A2/en active Application Filing
- 2002-03-07 DK DK02713823T patent/DK1399472T3/da active
-
2010
- 2010-03-04 IL IL204299A patent/IL204299A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60232511D1 (de) | 2009-07-16 |
CA2440596A1 (en) | 2002-09-19 |
JP2004536040A (ja) | 2004-12-02 |
EP1399472A2 (en) | 2004-03-24 |
WO2002072607A3 (en) | 2004-01-15 |
IL204299A (en) | 2011-06-30 |
AU2002245652A1 (en) | 2002-09-24 |
CA2440596C (en) | 2011-05-24 |
ATE432942T1 (de) | 2009-06-15 |
ES2327821T3 (es) | 2009-11-04 |
EA005496B1 (ru) | 2005-02-24 |
EP1399472B1 (en) | 2009-06-03 |
EA200300983A1 (ru) | 2004-06-24 |
DK1399472T3 (da) | 2009-10-05 |
WO2002072607A2 (en) | 2002-09-19 |
JP4009535B2 (ja) | 2007-11-14 |
EP1399472A4 (en) | 2004-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL157726A0 (en) | Soluble heterodimeric cytokine receptor | |
UA84830C2 (uk) | Розчинний рецептор інтерлейкіну-20 | |
CY1112787T1 (el) | Πολλαπλομερη του υποδοχεα κυτοκινης ζcytor17 | |
NO20050685L (no) | NOGO-reseptorantagonister | |
WO2004020405A3 (en) | Modified transferrin fusion proteins | |
BR0212256A (pt) | Proteìnas de fusão de transferrina modificadas | |
WO2004020404A3 (en) | Modified transferin-antibody fusion proteins | |
DE60333306D1 (de) | Modifizierte transferrin-fusionsproteine mit doppelten transferrin-amino- oder carboxy-terminalen domänen | |
CY1106594T1 (el) | Αντισωματα εναντι ανθρωπινης il-12 | |
PL336306A1 (en) | Proteinous fusions of tgf-beta ii type receptor with a constant immunoglobulin area | |
CY1112840T1 (el) | Πρωτεϊνες συντηξης ταci-ανοσοσφαιρινης | |
WO2004060295A3 (en) | Methods of inducing and maintaining immune tolerance | |
IL139419A (en) | Antibodies which cross-react with apo-2l receptor and compositions comprising them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |